Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    Open Studies | "Dwarfism"
Show Display Options
Rank Status Study
1 Recruiting Short Stature Related Distress
Conditions: Idiopathic Short Stature;   Self Image
Interventions: Drug: GH treatment (Genotropin);   Drug: 1 year treatment with placebo followed by optional 3 years of GH treatment
2 Recruiting Effect of Anesthesia on Quality of Recovery in Patients Undergoing Cosmetic Lower Limb Lengthening for Short Stature Correction - A Randomized Controlled Trial
Condition: Short Stature
Interventions: Drug: propofol and remifentanil;   Drug: desflurane and remifentanil
3 Recruiting Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children
Condition: Dwarfism, Pituitary
Intervention: Biological: PEG-somatropin
4 Not yet recruiting Fitness Level in Short Stature Children and After Growth Hormone Treatment
Condition: Fitness
Intervention: Other: change in fitness level
5 Recruiting Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole
Condition: Short Stature
Interventions: Drug: Letrozole;   Drug: Anastrozole
6 Recruiting Growth Hormone Secretion Following the Anaerobic Exercise
Condition: Short Stature
Intervention: Other: Anaerobic Test
7 Recruiting Evaluation and Intervention for the Effects of Osteogenesis Imperfecta
Conditions: Dwarfism;   Osteogenesis Imperfecta
Intervention:
8 Recruiting A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height
Condition: Idiopathic Short Stature
Interventions: Drug: somatropin;   Drug: triptorelin
9 Recruiting Evaluating the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Boys
Conditions: Growth Problem;   Low Weight;   Short Stature
Interventions: Dietary Supplement: Nutritional supplementation standardized formula;   Dietary Supplement: Placebo comparator
10 Recruiting Genetic Causes of Growth Disorders
Conditions: Short Stature;   Growth Disorder
Intervention:
11 Recruiting Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
Conditions: Obesity;   Short Stature;   Growth Hormone Deficiency
Interventions: Drug: Niacin;   Drug: Placebo
12 Recruiting The Impact of the Use of Recombinant Human Growth Hormone on ADHD Characteristics in Children and Adolescents
Conditions: Growth Hormone Deficiency;   Attention Deficit Disorder;   Idiopathic Short Stature
Intervention: Other: Questionnaires
13 Recruiting Versartis Long-Term Safety Study of Somavaratan
Condition: Pediatric Growth Hormone Deficiency
Intervention: Drug: somavaratan
14 Recruiting Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Biological: Jintropin AQ
15 Not yet recruiting Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Condition: Pediatric Growth Hormone Deficiency
Interventions: Drug: MOD-4023;   Drug: Somatropin
16 Recruiting Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: PEG-somatropin
17 Recruiting Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
Condition: Adult Growth Hormone Deficiency (AGHD)
Intervention: Drug: somavaratan
18 Recruiting Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Growth Hormone Deficiency in Children
Interventions: Drug: NNC0195-0092;   Drug: Norditropin® FlexPro® pen
19 Recruiting Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)
Condition: Growth Hormone Deficiency
Intervention: Biological: PEG-somatropin
20 Recruiting A Post-Marketing Open-Label Study of the Efficacy and Immunogenicity of Somatropin (Ribosomal Deoxyribonucleic Acid [rDNA] Origin) (Nutropin AQ®) in Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: Somatropin

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.